Paul R. Ingram
- Epidemiology top 10%
- Infectious Diseases top 5%
- Molecular Medicine top 1%
- Pharmacology top 2%
- Endocrinology top 2%
- Co-authors
- Dale FisherFiona L. HenriquezCraig W. RobertsDavid Chien LyeVincent H. TamTim InglisPaul Anantharajah TambyahWei Peng Goh
- Topics
- Antibiotics Pharmacokinetics and Efficacy (17 papers)Antibiotic Resistance in Bacteria (15 papers)Bacterial Identification and Susceptibility Testing (10 papers)
- Partner nations
- AustraliaUnited StatesSingapore
In The Last Decade
Paul R. Ingram
61 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 115
- Epidemiology 396
- Infectious Diseases 393
- Molecular Medicine 376
- Pharmacology 355
- Endocrinology 268
Countries citing papers authored by Paul R. Ingram
This map shows the geographic impact of Paul R. Ingram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul R. Ingram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul R. Ingram more than expected).
Fields of papers citing papers by Paul R. Ingram
This network shows the impact of papers produced by Paul R. Ingram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul R. Ingram. The network helps show where Paul R. Ingram may publish in the future.
Co-authorship network of co-authors of Paul R. Ingram
This figure shows the co-authorship network connecting the top 25 collaborators of Paul R. Ingram. A scholar is included among the top collaborators of Paul R. Ingram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul R. Ingram. Paul R. Ingram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 9 | |
| 7 | 18 | |
| 8 | 54 | |
| 9 | 19 | |
| 10 | 36 | |
| 11 | 46 | |
| 12 | 12 | |
| 13 | 75 | |
| 14 | 3 | |
| 15 | 13 | |
| 16 | 132 | |
| 17 | 5 | |
| 18 | 30 | |
| 19 | 29 | |
| 20 | 20 |
About Paul R. Ingram
Paul R. Ingram is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 61 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (15 papers) and Bacterial Identification and Susceptibility Testing (10 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (213 citations), Molecular Medicine (376 citations) and Endocrinology (268 citations). Paul R. Ingram has collaborated with scholars based in Australia, United States and Singapore. Frequent co-authors include Dale Fisher, Fiona L. Henriquez, Craig W. Roberts, David Chien Lye, Vincent H. Tam, Tim Inglis, Paul Anantharajah Tambyah, Wei Peng Goh, Christopher H. Heath and Charley Budgeon. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.